GRIFFIN MICHELLE RENEE sold 76.9% of their position (52.08K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $1.05M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/29/2026ACC: 0001229765-26-000008
Director
Since Jun 2019
-52.08K
Net shares
Net seller
$1.05M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
52.08K acquired · 104.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+52.08K
Price / share
$7.80
Trade value
$406.26K
% of position
333.3%
6/25/2026
15.63K→67.71K
Common Stock
Direct
Shares
−52.08K
Price / share
$20.18
Trade value
$1.05M
% of position
76.9%
6/25/2026
67.71K→15.63K
Total
Net shares
+0.00
Net value
-$644.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2026 | M · Option Exercise | +52.08K | $7.80 | $406.26K | 333.3% | 15.63K | 67.71K |
| Common Stock Direct | 6/25/2026 | S · Sale | −52.08K | $20.18 | $1.05M | 76.9% | 67.71K | 15.63K |
| Total | +0.00 | -$644.80K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
52.08K shares
Shares
−52.08K
Strike price
7.80
Held after
0.00
Exercisable
—
6/25/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock52.08K shares | 6/25/2026 | M · Option Exercise | −52.08K | 7.80 | — | 0.00 |